A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies

Bone Marrow Transplantation

Volumn 25, Issue 8, 2000, Pages 807-813

  Sobecks, R M ^a   Daugherty, C K ^a   Hallahan, D E ^a   Laport, G F ^a   Wagner, N D ^a   Larson, R A ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Dose escalation; Etoposide; Hematologic malignancies; High energy radiation; Leukemia; TBI

Indexed keywords

ANTINEOPLASTIC ALKALOID; ETOPOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LIVER TOXICITY; LUNG TOXICITY; MALE; MORTALITY; MUCOSA INFLAMMATION; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PRIORITY JOURNAL; RADIATION DOSE; STEM CELL TRANSPLANTATION; THROMBOCYTE; WHOLE BODY RADIATION;

EID: 0034074068     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702230     Document Type: Article

References (32)

1. Thomas ED, Storb R, Clift A et al. Bone marrow transplantation. New Engl J Med 1975; 292: 832-843, 895-902.
2. Thomas ED, Buckner CD, Banaji M et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation (TBI) and allogeneic marrow transplantation. Blood 1977; 49: 511-533.
3. Forman SJ, Blume K, Thomas ED. Bone Marrow Transplantation, 1st edn. Little Brown and Co: Baltimore, 1994.
4. Blume KG, Forman SJ, O'Donnell MR et al. Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood 1987; 69: 1015-1020.
5. Blume KG, Kopecky KJ, Henslee-Downey JP et al. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group Study. Blood 1993; 81: 2187-2193.
6. Brown RA, Wolff SN, Fay JW et al. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Transplant Group. Blood 1995; 85: 1391-1395.
7. Kim TH, McGlave PB, Ramsay N et al. Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. Int J Radiat Oncol Biol Phys 1990; 19: 889-897.
8. McGlave PB, Arthur DC, Kim TH et al. Successful allogeneic bone marrow transplantation for patients in the accelerated phase of chronic granulocytic leukemia. Lancet 1982; 2: 625-627.
9. Michel G, Gluckman E, Blaise D et al. Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission for acute myeloid leukemia: a report from the Group d'Etude des Greffes de Moelle Osseuse. J Clin Oncol 1992; 10: 1865-1869.
10. Schmitz N, Gassmann W, Rister M et al. Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias. Blood 1988; 72: 1567-1573.
11. Spitzer TR, Peters C, Ortlieb M et al. Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and children. Int J Radiat Oncol Biol Phys 1994; 29: 39-44.
12. Spruce WE. Bone Marrow Transplantation. I. Use in neoplastic diseases (review). Am J Public Health 1983; 5: 287-294.
13. Deeg HJ, Storb R, Longton G et al. Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: effects of exposure rate, fraction size and fractionation interval on acute and delayed toxicity. Int J Radiat Oncol Biol Phys 1988; 15: 647-653.
14. Deeg HJ, Storb R, Weiden PL et al. High-dose total body irradiation and autologous marrow reconstitution in dogs: dose-rate-related acute toxicity and fractionation-dependent long-term survival. Radiat Res 1981; 88: 385-391.
15. Hagenbeek A, Martens ACM. The effect of fractionated versus unfractionated total body irradiation on the growth of the BN acute myelocytic leukemia. Int J Radiat Oncol Biol Phys 1981; 7: 1075-1079.
16. Lichter AS, Tracy D, Lam WC et al. Total body irradiation in bone marrow transplantation: the influence of fractionation and delay of marrow infusion. Int J Radiat Oncol Biol Phys 1980; 6: 301-309.
17. Deeg HJ, Sullivan KM, Buckner CD et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant 1986; 1: 151-157.
18. Dinsmore R, Kirkpatrick D, Flomenberg N et al. Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia. Blood 1983; 62: 381-388.
19. Thomas ED, Clift RA, Hersman J et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or single-dose irradiation. Int J Radiat Oncol Biol Phys 1982; 8: 817-821.
20. Cosset JM, Socie G, Dubray B et al. Single dose versus fractionated total body irradiation before bone marrow transplantation: radiobiological and clinical considerations. Int J Radiat Oncol Biol Phys 1994; 30: 477-492.
21. Petersen FB, Deeg HJ, Buckner CD et al. Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide-A phase I trial. Int J Radiat Oncol Biol Phys 1992; 23: 1027-1032.
22. Clift RA, Buckner CD, Appelbaum FR et al. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood 1991; 77: 1660-1665.
23. Bradley J, Reft C, Goldman S et al. High-energy total body irradiation as preparation for bone marrow transplantation in leukemia patients: treatment technique and related complications. Int J Radiat Oncol Biol Phys 1998; 40: 391-396.
24. Sibley GS, Mundt AJ, Goldman S et al. Patterns of failure-following total body irradiation and bone marrow transplantation. Int J Radiat Oncol Biol Phys 1995; 32: 1127-1135.
25. Cancer Therapy and Evaluation Program. Common toxicity critera. In: NCI Division of Cancer Treatment Guidelines for Reporting of Adverse Drug Reactions. National Cancer Institute: Bethesda, MD, 1989.
26. Quast U. Total body irradiation. Review of treatment techniques in Europe. Radiother Oncol 1987; 9: 91-106.
27. Shank B. Techniques of magna field irradiation. Int J Radiat Oncol Biol Phys 1983; 9: 1925-1931.
28. Shank B. Total body irradiation for marrow or stem cell transplantation. Cancer Invest 1998; 16: 397-404.
29. Lindsley K, Deeg HJ. Total body irradiation for marrow or stem cell transplantation. Cancer Invest 1998; 16: 424-425.
30. Clift RA, Buckner CD, Bianco J et al. Marrow transplantation in patients with acute myeloid leukemia. Leukemia 1992; 6 (Suppl. 2): 104-109.
31. Clift RA, Buckner CD, Applebaum FR et al. Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia. Blood 1998; 92: 1455-1456.
32. Dopfer R, Henz G, Bender-Gotze C et al. Allogeneic bone marrow transplantation for childhoood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM and CoAll protocols. Results of the German Cooperative Study. Blood 1991; 78: 2780-2784.